PATENT CLAIM ANALYSIS

Application Number: 16237893
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-04
Patent Classification: ["530", "326000"]

Abstract:
The present invention provides modulators of complement activity. Also provided are methods of utilizing such modulators as therapeutics.

Claim (Index 21):
The method of  claim 18 , wherein the complement-related disease, disorder, or condition is selected from the group consisting of an inflammatory indication, a wound, an injury, an autoimmune disease, a vascular indication, a neurological indication, a kidney-related indication, an ocular disease, paroxysmal nocturnal hemoglobinuria, and atypical hemolytic uremic syndrome.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 99.0
- Lexical Diversity: 1.17647
- Patent Class: 530.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16128561', '15318063', '15905158', '15547085', '14962457']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8323685771034355
- 35 USC 102 Novelty (BERT): 0.6217448691475679
- Combined Prediction Score: 0.8113062063078488
- Mean Citation Score: 504.10272
- Max Citation Score: 611.3871
- Similarity Product: 482.08278006294967

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test